We are thrilled to share exciting news at Smart MCs! A pioneering partnership has been forged with Macquarie University, focusing on the development of an AI-based predictive model for the reliability assessment of microcarriers. This collaborative project is part of a pilot research initiative, generously funded by both Smart MCs and Macquarie University under the [...]
Recent research spearheaded by Stanford scholars has shed light on the pioneering use of induced pluripotent stem cells (iPSCs) in cardiac tissue engineering (Link to Source Article). This innovative approach not only promises to revolutionize our understanding of cardiovascular diseases but also paves the way for new therapeutic strategies. Here’s what you need to [...]
Induced pluripotent stem cells (iPSCs) represent a cornerstone in regenerative medicine and biotechnological research. These versatile cells are generated from somatic cells and can differentiate into nearly any cell type, making them invaluable for applications such as disease modeling, drug testing, and potentially, organ regeneration. Recognizing their potential, the European Bank for induced pluripotent [...]
A recent review publication has shed light on the monumental potential of functional polymer surfaces in steering cell behavior, marking a significant advancement in the realms of biomedical engineering, tissue engineering, and cell-based assays. This paper, freely accessible online, delves into the critical role [...]
We are pleased to announce the publication of a significant review by our very own Dr. Christopher J. O'Keeffe, in collaboration with esteemed scientists from the University of Sydney, University of New South Wales, and University of the Sunshine Coast. This review, published in the prestigious journal Trends in Biotechnology, focuses on a crucial aspect [...]
In the realm of biotechnology, the quest for more efficient methods to cultivate cells for vaccine production is ongoing. A recent paper titled "Seed Train Optimization in Microcarrier-Based Cell Culture Post In Situ Cell Detachment through Scale-Down Hybrid Modeling" has offered a promising breakthrough that could significantly enhance the scalability and efficiency of viral [...]
Sydney's biomaterials leader, Smart MCs PTY LTD, was selected fora notable grant from Therapeutic Innovation Australia (TIA) to explore the potential of novel microcarriers in scaling up the production of Mesenchymal Stem Cells (MSCs) for clinical use. This project is a collaborative effort with the team of Dr. Zlatibor Velickovic at Cell & Tissue Therapies [...]
Human embryonic kidney 293 (HEK293) cells are widely utilised in research and bioprocessing industries, yet scaling up their growth poses significant challenges. Check out the 2020 study by Iuchi et al., published in Cytotechnology, which delves into the various morphologies of human embryonic kidney 293T cells in [...]
In a significant leap towards advancing stem cell research and biotechnology, Smart MCs PTY LTD is thrilled to announce its collaboration with Associate Professor Khoon Lim on a groundbreaking project, "Designing Biofunctional Microcarriers for Stem Cell Expansion." This initiative has successfully secured seed funding from the University of Sydney's Faculty of Engineering Seed Funding [...]
